Pilar Nava-Parada: I am proud to be participating in The Leukemia and Lymphoma Society Visionaries
Pilar Nava-Parada, Senior Medical Team Lead and US Medical Chief of R&D oncology at
“Today marks the opening of The Leukemia and Lymphoma Society Visionaries of the Year campaign, and I am proud to be participating.
- Visionaries look to the future and see infinite possibilities.
- We challenge the status quo–and make the impossible possible.
- We boldly imagine a better world–and lead a change or create it.
My vision is to accelerate the development of better and safer cancer treatments, making cancer manageable like any other chronic disease. I envision a world where there are more survivors like myself, living happy lives.
As a global leader in the fight against cancer, my mission is to support the Therapy Acceleration Program (TAP), a strategic venture philanthropy initiative that seeks to accelerate the development of innovative blood cancer therapeutics.
TAP collaborates with scientists and biotech to help develop novel platforms and first-in-class medicines that address unmet medical needs, help for emerging and underserved populations, and rare cancers.
Together, we can make a difference and lead the change towards a world where cancer no longer takes lives. Please consider becoming a sponsor and share my link through your network. Your support saves lives.
Click here to donate today (Tax-deductible).”
Source: Pilar Nava-Parada/LinkedIn
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023